Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of PG-011 gel in adults with mild-to-moderate atopic dermatitis
CTR20210610Phase 2Completed
- Sponsor
- Puqi Pharma
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pumecitinib in atopic dermatitis (AD), sponsored by Puqi Pharma. Started Apr 2021; status: completed.
02
Drugs
pumecitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20210610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210610.